Kim, J.H.; Yoon, J.H.; Kim, S.-E.; Park, J.-W.; Park, Y.; Kim, G.-A.; Na, S.K.; Lee, Y.-S.; Kim, J.H.
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study. Medicina 2025, 61, 1601.
https://doi.org/10.3390/medicina61091601
AMA Style
Kim JH, Yoon JH, Kim S-E, Park J-W, Park Y, Kim G-A, Na SK, Lee Y-S, Kim JH.
Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study. Medicina. 2025; 61(9):1601.
https://doi.org/10.3390/medicina61091601
Chicago/Turabian Style
Kim, Jung Hee, Jae Hyun Yoon, Sung-Eun Kim, Ji-Won Park, Yewan Park, Gi-Ae Kim, Seong Kyun Na, Young-Sun Lee, and Jeong Han Kim.
2025. "Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study" Medicina 61, no. 9: 1601.
https://doi.org/10.3390/medicina61091601
APA Style
Kim, J. H., Yoon, J. H., Kim, S.-E., Park, J.-W., Park, Y., Kim, G.-A., Na, S. K., Lee, Y.-S., & Kim, J. H.
(2025). Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study. Medicina, 61(9), 1601.
https://doi.org/10.3390/medicina61091601
